Press release Named to Inc. 500 List for Third Consecutive Year with Three-Year Revenue Growth of 1,522%

Sponsored by Businesswire

Inc. magazine today revealed that, the world’s largest enterprise marketplace for outsourced R&D services, ranked no. 289 on its Inc. 5000 list, the prestigious ranking of the nation’s fastest-growing private companies. The annual ranking, now in its 38th year, represents a unique look at the most successful companies within the American economy. Microsoft, Dell, Pandora, LinkedIn, Yelp, Zillow and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“Our mission at is to empower and connect scientists worldwide – and make it possible to cure all human diseases by 2050,” stated Kevin Lustig, PhD,’s CEO and Founder. “We are succeeding because of the hard work, talent and dedication of our incredible employees.”

Founded out of Lustig’s home in 2007, is the pharmaceutical industry’s leading enterprise gateway marketplace. By connecting research scientists and facilitating the creation and purchase of complex services and products, enables pharma and biotech companies to save time, reduce costs and promote innovation, while also ensuring that all transactions are compliant with internal regulations. With such a strong value proposition, has the potential to solve the major challenge facing the pharmaceutical industry – how to create more drugs for less money and in less time.

“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc. editor in chief James Ledbetter. “There’s no single course you can follow or investment you can take that will guarantee this kind of spectacular growth. But what they have in common is persistence and seizing opportunities.”

Complete results of the Inc. 5000, including company profiles and an interactive database can be found at and other top-500 companies are featured in the September issue of Inc.

About is the world’s leading enterprise gateway marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saving time and money, reducing risk and providing access to the latest innovative tools and technologies. operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit to learn more.

Join on social media: LinkedIn, Twitter, Facebook, Instagram and YouTube.